Clinical Trial Update: Vaccine Therapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

The document reports an Epimmune-sponsored Phase 2 trial of a vaccine therapy for stage IIIB, stage IV, or recurrent non-small cell lung cancer; the study statu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Vaccine therapy

Snippet

Sponsor: Epimmune | Conditions: Lung Cancer | Phase 2 | Status: UNKNOWN